Loading...
Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma – an auto-commentary on clinical potential and future development
Immunotherapy has shown great promise to transform solid cancer treatment. The challenge is to optimally incorporate novel immunotherapeutics, such as immune checkpoint blockers, with standard therapies. This is well exemplified by multimodal therapies recently developed for liver cancer in which im...
Saved in:
| Published in: | Oncoimmunology |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4589048/ https://ncbi.nlm.nih.gov/pubmed/26451297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1029703 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|